Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility

Elaine T. Buchert, Raymond L. Woosley, Sandra M. Swain, Stephen J. Oliver, Steven S. Coughlin, Linda Pickle, Bruce Trock, Anna Tate Riegel

Research output: Contribution to journalArticle

21 Scopus citations
Original languageEnglish (US)
Pages (from-to)322-327
Number of pages6
JournalPharmacogenetics
Volume3
Issue number6
DOIs
StatePublished - Dec 1993

All Science Journal Classification (ASJC) codes

  • Genetics
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Buchert, E. T., Woosley, R. L., Swain, S. M., Oliver, S. J., Coughlin, S. S., Pickle, L., Trock, B., & Riegel, A. T. (1993). Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility. Pharmacogenetics, 3(6), 322-327. https://doi.org/10.1097/00008571-199312000-00006